#regulation

• Peptides Are Booming — But U.S. Regulators Are Moving In
  2026-03-09

  Demand for peptide therapies is surging, but U.S. regulators are tightening oversight of compounded GLP-1 drugs, research peptides, and clinic marketing claims.

  Tags: analysis, longevity, biotech, regulation